Molecule Details
InChIKeyNSICSOQWNRELKK-ZRLZNKEGSA-N
Compound Name(2R,12Z,13aS,14aR,16aS)-2-({8-Chloro-7-methoxy-2-[4-(propan-2-yl)-1,3-thiazol-2-yl]quinolin-4-yl}oxy)-N-(cyclopropylsulfonyl)-5,16-dioxo-1,2,3,6,7,8,9,10,11,13a,14,15,16,16a-tetradecahydrocyclopropa[g]pyrrolo[1,2-c][1,3,6]triazacyclopentadecine-14a(5H)-carboxamide
Canonical SMILESCOc1ccc2c(O[C@@H]3C[C@H]4C(=O)N[C@]5(C(=O)NS(=O)(=O)C6CC6)C[C@H]5/C=C\CCCCCNC(=O)N4C3)cc(-c3nc(C(C)C)cs3)nc2c1Cl
Clinical Status Data-mined Candidate
Targets (Human+Pathogen)4
Pfam Stratification Cross-Family
Avg pChEMBL10.0
SourceBindingDB;ChEMBL
2D Structure
2D structure
Activity Profile
Target Activities (4)
Target Gene Organism Category Pfam pChEMBL Type Source
A3EZI9 NS3 Hepacivirus hominis Pathogen PF07652 PF22027 PF02907 10.0 Ki ChEMBL
B0B3F0 NS3/4A Hepacivirus hominis Pathogen PF07652 PF01006 PF22027 PF02907 10.0 Ki BindingDB
D2K2A8 NS4A Hepacivirus hominis Pathogen PF01006 10.0 Ki ChEMBL
K7XGM7 Hepacivirus hominis Pathogen PF07652 PF01006 PF22027 PF02907 10.0 Ki BindingDB